Salute e Benessere

Antimicrobial Susceptibility Testing Market to be Worth $7.21 Billion by 2031 -…

Antimicrobial Susceptibility Testing (AST) is used to determine the antimicrobial regimen to identify susceptibility/resistance against pathogens. Antimicrobial susceptibility tests guide physicians in drug choice and dosage. Antimicrobial resistance is a result of the misuse and overuse of antimicrobials. As per WHO estimates, at least 700,000 people die each year due to drug-resistant diseases, making it a global threat. The deaths due to antimicrobial resistance can climb up to 10 million…
PR Newswire
06/06/2024

AI Based Wound Care Software Market to Record an Exponential CAGR by 2031 -…

Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/2519 Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/2519 List of Prominent Players in the AI Based Wound Care Software Market: Buy 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2519 Market Dynamics: Drivers: The growing incidence of chronic wounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers,...
PR Newswire
06/06/2024

Peptide Drug Discovery Market Expected to Grow at a 11.3% CAGR from 2024-2031|…

Peptide drugs have emerged as a promising class of therapeutic agents, due to their high specificity and low toxicity to target specific biological pathways. The process of peptide drug discovery involves a multifaceted approach, integrating advances in chemistry, biology, and computational methods. Peptide drugs have emerged as a promising class of therapeutic agents, due to their high specificity and low toxicity to target specific biological pathways. The process of peptide drug discovery...
PR Newswire
06/06/2024

Nannochloropsis Market to Reach $14.0 Million by 2031 - Exclusive Report by…

Nannochloropsis is a genus of microalgae from the phylum Ochrophyta, class Eustigmatophyceae. These unicellular algae are spherical or oblong, measuring 2-5 microns in diameter. Nannochloropsis sp. contains high amounts of omega-3 fatty acids in the form of eicosapentaenoic acid (EPA), which is a vegan alternative to fish oil. Moreover, the high content of proteins present in Nannochloropsis makes it a very interesting nutritional profile. Nannochloropsis cell mass comprises 50–55% crude…
PR Newswire
06/06/2024

Ardena appoints Jeremie Trochu as Chief Executive Officer

"We are thrilled to welcome Jeremie to Ardena," says Alan MacKay, Managing Partner and Founder, GHO Capital, which acquired Ardena in 2019. "His track record of driving growth and value creation aligns with our shared vision for Ardena's future. His global mindset and extensive experience and network across the US market will support our ambitions for future international expansion." "We are thrilled to welcome Jeremie to Ardena," saysAlan MacKay, Managing Partner…
PR Newswire
06/06/2024

Tiziana Life Sciences Announces Six-Month Qualitative Improvement in…

Qualitative improvements in PET imaging seen in 80% of non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access patients receiving intranasal foralumab for at least 6-months.FDA Allowance for an additional 20 Patients to be enrolled in the intranasal foralumab Multiple Sclerosis Expanded Access Program will allow further data collection and analysis.Applied for FDA Orphan Drug Designation of foralumab for na-SPMS NEW YORK, June06, 2024(GLOBE NEWSWIRE) -- Tiziana...
Nasdaq GlobeNewswire
06/06/2024

Databricks Doubles Down on Delta Sharing Open Ecosystem With Product Innovations…

SAN FRANCISCO, June 6, 2024 /PRNewswire/ -- Databricks, the Data and AI company, today announced new and expanded strategic partnerships for data sharing and collaboration with industry-leading partners, including Acxiom, Atlassian, Epsilon, HealthVerity, LiveRamp, S&P Global, Shutterstock, T-Mobile, Tableau, TetraScience, and The Trade Desk. Databricks' investments in its open data and AI ecosystem enable customers to efficiently collaborate across platforms and unlock AI innovation. SAN...
PR Newswire
06/06/2024

Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer   

PARIS, FRANCE, 06 June 2024 -Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Josep Catllà as EVP, Chief Corporate Affairs Officer, effective August 19, 2024. He will serve on the Executive Leadership Team (ELT) and report directly to Ipsen's Chief Executive Officer (CEO), David Loew. “We are thrilled to welcome Josep to Ipsen as our new Chief Corporate Affairs Officer, as h. He brings years of experience inof...
Nasdaq GlobeNewswire
06/06/2024

Virbac : Declaration of the number of shares and voting rights 05/2024

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsMay, 31 20248 458 000Gross total of voting rights :...
Nasdaq GlobeNewswire
06/06/2024

Zealand Pharma announces that Boehringer Ingelheim will present positive results…

Company announcement - No. 29 / 2024 Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASLCopenhagen, Denmark, June 6, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) today announced that an embargoed abstract of positive results from Boehringer Ingelheim's Phase 2 trial of survodutide (BI 456906) in metabolic dysfunction-associated steatohepatitis (MASH) due to be presented at the European Association of the Study...
Nasdaq GlobeNewswire
06/06/2024

European Bioplastics elects new Board with Mariagiovanna Vetere and Franz Kraus…

European Bioplastics (EUBP), the association representing the interests of the bioplastics industry in Europe, has elected a new Board during its General Assembly on 4 June.For the next two years, the EUBP leadership team will be headed by Co-Chairs Mariagiovanna Vetere (Natureworks) and Franz Kraus (Novamont), and supported by the new Vice-Chair, Afsaneh Nabifar (BASF). Andy Sweetman (Futamura), Frédéric Van Gansberghe (Futerro), Myriam Moeyersons (Ingevity), Robert Mack...
Nasdaq GlobeNewswire
06/06/2024

Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by…

Key Takeaways from the Carotid Artery Stent Market Report Key Takeaways from the Carotid Artery Stent Market Report To read more about the latest highlights related to the carotid artery stent market, get a snapshot of the key highlights entailed in theGlobal Carotid Artery Stent Market Report Carotid Artery Stent Overview Carotid artery stenting is a minimally invasive procedure used to treat carotid artery disease, a condition where the carotid arteries, located in the...
PR Newswire
06/06/2024

Incentive programs for the Executive Leadership Team, the Senior Leadership Team…

June 6, 2024Company announcement No. 20 Incentive program for the Executive Leadership Team 2024-2026 In line with previous year, a new long-term incentive program (LTI) for the Executive Leadership Team covering the performance period 2024-2026 has been established. The program complies with the Remuneration Policy for the Executive Management and the Board of Directors of Novonesis, as approved at Novonesis Annual Shareholders' Meeting on April 30, 2024. The LTI consists...
Nasdaq GlobeNewswire
06/06/2024

ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen…

Proceeds to support development of ITM's targeted radiopharmaceutical pipeline and preparations for potential market launch of phase III lead candidate, ITM-11, as it nears clinical read-out Funds will also enable expansion of manufacturing capabilities for the production of alpha- and beta-emitting radioisotopes, including Lutetium-177 ( 177 Lu) and Actinium-225 ( 225 Ac) Garching / Munich, Germany, June 06, 2024 –ITM Isotope Technologies Munich SE (ITM) , a leading...
Nasdaq GlobeNewswire
06/06/2024

Cambridge Medical & Rehabilitation Center Unveils New Building in Al Ain…

To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/9273351-cambridge-medical-rehabilitation-center-new-building-al-ain-facility/ To view the Multimedia News Release, please click:https://www.multivu.com/players/uk/9273351-cambridge-medical-rehabilitation-center-new-building-al-ain-facility/ Strategically situated inAl Aincity, the state-of-the-art facility embodies CMRC's commitment to revolutionizing post-acute and rehabilitation services across the...
PR Newswire
06/06/2024

Department of Health - Abu Dhabi and AstraZeneca Expand Partnership During BIO…

Data suggests genetic and congenital disorders are more common in the Arab Gulf than in other industrialised countries, leading to a high socio-economic burden on patients, families and communities. This collaboration will help to address this burden by allowing the two entities to work together to establish a Rare Disease Centre of Excellence in the Emirate, serving as a hub for comprehensive diagnosis, treatment, follow-up, research education and patient care with a focus on haematology…
PR Newswire
06/06/2024

Alchemab advances a novel antibody with potential in Parkinson's disease with…

Alchemab's antibodies were discovered using its innovative platform which integrates advanced proteomics, bioinformatics, and machine learning in the analysis of patient samples to find signals associated with resilience to disease. Using samples from patients predisposed to PD symptoms and samples from patients with a typical disease course, Alchemab identified a target it believes may contribute to disease resistance. Its research explores how the prostaglandin pathway impacts disease…
PR Newswire
06/06/2024

Cat Litter Market to Reach $13.7 billion, Globally, by 2035 at 4.7% CAGR: Allied…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15878 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A15878 Prime determinants of growth Increase in pet ownership rates globally, particularly in urban areas, drive demand for cat litter products. Moreover, rise in awareness of pet hygiene and the importance of odor control fuel market growth. Innovations in cat litter technology,...
PR Newswire
06/06/2024

Sequana Medical announces data on alfapump® safety and quality of life to be…

Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024 “alfapump implantation significantly improved quality of life and showed similar safety outcomes compared to a contemporaneously enrolled refractory ascites cohort”;oral poster presentation by Dr. BajajMatched cohort analysis of patients from North American pivotal alfapump study (POSEIDON) vs. contemporaneous NACSELD3 studyStrong commercial positioning for...
Nasdaq GlobeNewswire
06/06/2024

EUROAPI reaches major Health IPCEI milestone with official notification from…

Press Release Paris – June 6, 2024– EUROAPI has received official notification from the European Commission that the Company has been selected as one of the 13 companies eligible to share up to EUR 1 billion in total public funding under the Important Project of Common European Interest (IPCEI) dedicated to the pharmaceutical sector, “IPCEI Med4Cure”.This IPCEI had been jointly notified by six Member States of the European Union, i.e. France, Belgium, Hungary,...
Nasdaq GlobeNewswire
06/06/2024

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate…

● GABAB PAM: Selection of drug candidates under Indivior collaboration expected by end of Q2 2024 . Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, June 6, 2024-Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its Q1 2024 financial results and provided a corporate update.“Building on the recent...
Nasdaq GlobeNewswire
06/06/2024

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority) PARIS, June05, 2024(GLOBE NEWSWIRE) -- Listing market: Euronext GrowthISIN code: FR0010425595DateTotal number of shares in the capitalTotal number of voting rights 05/31/2024100,093,63588,029,374 For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,media@cellectis.com Patricia...
Nasdaq GlobeNewswire
05/06/2024

DBV Technologies to Participate in the Goldman Sachs 45th Annual Global…

DBV Technologies to Participate in the Goldman Sachs 45 thAnnual Global Healthcare ConferenceDBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced that Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the 45 thAnnual Goldman Sachs Global...
Nasdaq GlobeNewswire
05/06/2024

Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global…

Media ReleaseCOPENHAGEN, Denmark; June 05, 2024 Genmab A/S (Nasdaq:GMAB) announced today that its Chief Financial Officer Anthony Pagano and Chief Operating Officer Anthony Mancini will participate in a fireside chat at the Goldman Sachs 45 thAnnual Global Healthcare Conference in Miami Beach , Florida9:20AM EDT(3:20 PM CEST) on June 10 , 2024 .A webcast of the fireside chat will be available on Genmab's website athttps://ir...
Nasdaq GlobeNewswire
05/06/2024
Altri  Comunicati